Massive study to uncover cancer Therapy's hidden toll on fertility
NCT ID NCT07622537
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This large observational study will follow 4,000 young cancer survivors (ages 15-39) across Europe to understand how different cancer treatments impact fertility, hormone function, and pregnancy outcomes. Researchers will also evaluate the safety and success of fertility preservation methods. The goal is to provide better, personalized advice to patients about their reproductive future after cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict fertility risks after cancer treatment and improve counseling for young survivors.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve fertility, and results may take years to influence care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AYA CANCER SURVIVORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can 'Abnormal' embryos still lead to healthy pregnancies? a new registry investigates
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare